Genenta Science S.p.A. (GNTA)
- Simply Wall St.
3 US Penny Stocks With Market Caps Over $30M To Consider
The U.S. stock market has recently shown resilience, with the Dow Jones and S&P 500 inching higher following a benign CPI inflation reading. In this context, investors might find value in exploring penny stocks, which despite their somewhat outdated moniker, continue to offer intriguing opportunities for growth. These typically smaller or newer companies can present a blend of affordability and potential when backed by strong financials.
- GlobeNewswire
Genenta’s CEO to present at the U.S. Senate meeting on “Cross-Border Investments and Strategies in the Biotechnology Sector: A Transatlantic Perspective”
MILAN and NEW YORK, Oct. 23, 2024 (GLOBE NEWSWIRE) -- Genenta Science (NASDAQ: GNTA), a pioneer in immuno-oncology and in cell-based therapeutics, is pleased to announce that Pierluigi Paracchi, CEO, will attend as a speaker to the Italy-U.S. meeting “Cross-Border Investments and Strategies in the Biotechnology Sector: A Transatlantic Perspective” scheduled at 2.00 PM on October 25th, 2024 at the U.S. Senate - Washington, D.C. The event is organized by the U.S. National Security Commission on Em
